Last edition
News about "Harbour Mice"
Harbour BioMed and Sinopharm Partner to Advance Research and Development
Harbour BioMed and Sinopharm have partnered to establish an innovation Research and Development (R&D) consortium focused on biologics for oncology and immune-mediated diseases.
Harbour Mice | 28/07/2026 | By News Bureau
Nona Biosciences Expands Discovery-to-Clinical Capabilities
Nona Biosciences has strengthened its integrated discovery-to-clinical framework by expanding proprietary platform technologies and enhancing preclinical and early clinical development capabilities, including CMC development, toxicology and clinical operations.
Harbour Mice | 24/12/2025 | By News Bureau | 168
Nona Biosciences and Valink Partner to Advance Biologics Discovery
Nona Biosciences and Valink Therapeutics have partnered to advance biologics discovery by combining Nona’s Harbour Mice fully human antibody technologies, including heavy chain-only antibodies, with Valink’s LiliumX discovery platform to generate and screen thousands of novel drug candidates.
Harbour Mice | 18/12/2025 | By News Bureau | 166
Nona Biosciences, Kodiak Sciences to Power Next-Gen Antibody Therapies for Ophthalmic Diseases
The Harbour Mice platform generates fully human monoclonal antibodies in both the two heavy and two light chains (H2L2) format and the heavy chain-only (HCAb) format, eliminating the need for additional engineering or humanization.
Harbour Mice | 11/12/2024 | By Aishwarya | 444
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy